# Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis

> **NCT00868751** · NA · TERMINATED · sponsor: **Tufts Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Arthritis, Juvenile Rheumatoid
- Still's Disease, Juvenile Onset

## Interventions

- **BIOLOGICAL:** tocilizumab

## Key facts

- **NCT ID:** NCT00868751
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Hyperintensities of unclear etiology on brain MRI. Follow up revealed no progression.
- **Last updated:** 2017-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868751, "Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00868751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*